Capricor Therapeutics Stock Predictions

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

CAPR
Capricor Therapeutics

Last Price:

$13.49

Seasonality Move:

-1.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Google closes secret $20B deal with Apple to become iPhone's default search engine

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Capricor Therapeutics Stock Forecast

Over the next 52 weeks, Capricor Therapeutics has on average historically risen by 10.2% based on the past 18 years of stock performance.
Capricor Therapeutics has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%
Is Capricor Therapeutics Stock Undervalued?

The current Capricor Therapeutics [CAPR] share price is $13.28. The Score for CAPR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
CAPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Capricor Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Capricor Therapeutics has on average historically risen by 10.2% based on the past 18 years of stock performance.

Capricor Therapeutics Stock Rating

Sell

Capricor Therapeutics (CAPR) is a Sell

Is Capricor Therapeutics overpriced?

Capricor Therapeutics has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%

Capricor Therapeutics Stock Price History

Is CAPR stock going to rise?

The current trend is relatively stagnant and CAPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

capricor.com

52-Week Data

52-Week High:

23.40

52-Week Low:

3.52

Prediction Charts

Market Cap:

605.3M

Price in USD:

13.28

Volume:

803.7K

Beta:

1.16

Technical Analysis

SMA50:

14.02

SMA100:

15.47

SMA200:

11.34

52-Wk Change:

108.15%

Stock Predictions

Is Capricor Therapeutics stock public?

Yes, Capricor Therapeutics is a publicly traded company.
What is the Capricor Therapeutics stock quote today?

The Capricor Therapeutics stock price is 13.28 USD today.
How to buy Capricor Therapeutics stock online?

You can buy Capricor Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-5	13.90	12.65	14.18	12.05
Mar-6	12.56	13.59	14.01	12.29
Mar-7	13.68	12.81	13.90	12.73
Mar-11	12.34	12.57	13.14	11.75
Mar-12	12.93	13.07	13.34	12.55
Mar-13	13.08	12.79	13.42	12.67
Mar-14	13.00	13.23	13.40	12.80
Mar-17	13.32	12.88	13.92	12.68
Mar-18	12.88	11.61	12.94	11.55
Mar-19	11.76	12.22	12.38	11.60
Mar-20	12.56	14.36	14.75	12.23
Mar-21	14.16	12.86	14.16	12.75
Mar-24	13.13	13.28	13.32	12.64
Mar-25	13.20	13.48	13.68	12.86

Capricor Therapeutics Earnings

Capricor Therapeutics Earnings Report: Per Share Capricor Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Capricor Therapeutics Forecast Revenue Growth

Capricor Therapeutics Stock Analysis: Historical quarterly revenues per share for Capricor Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.57 per share, an increase this year of $0.84 per share, and an increase next year of $0.18 per share.

* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.